Taken together, DDR2′s dual role in regulating tissue remodeling and inflammation, combined with its interactions with established therapeutic targets like VEGF and HIF‐1α, positions DDR2 as a promising novel target for therapeutic intervention in endometriosis. Here, VEGFA is linked to endometriosis.